Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?
Read Full NewsA groundbreaking study reveals that combining ixekizumab and tirzepatide significantly improves outcomes for adults with psoriatic arthritis and obesity.
Coya Therapeutics reveals promising results for COYA 302, a potential treatment for frontotemporal dementia, showing cognitive stability and Treg enhancement.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the International Stroke Conference (ISC)!
Here's some of what is coming soon to NeurologyLive® this week.
FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
3.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
4.
Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method
5.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
1.
Understanding Sideroblastic Anemia and its Symptoms
2.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
3.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
4.
AI in Cancer Diagnostics and Imaging Interpretation
5.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge